Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Marilyn K. Glassberg, David Kardatzke, Talmadge E. King, Lisa Lancaster, Steven A. Sahn, Javier Szwarcberg, Dominique Valeyre, Roland M. du Bois
Topics & Concepts
PirfenidoneMedicineIdiopathic pulmonary fibrosisPlaceboInternal medicinePulmonary function testingVital capacityClinical endpointPulmonary fibrosisClinical trialLungGastroenterologySurgeryLung functionDiffusing capacityPathologyAlternative medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisRespiratory and Cough-Related ResearchCystic Fibrosis Research Advances